AnaptysBio的ANB032正在推进到Phase 2b ARISE-AD试验，而rosnilimab正在进行Phase 2b RENOIR RA试验。imsidolimab（一种用于治疗全身性脓疱型银屑病的药物）的GEMINI-1和GEMINI-2 Phase 3试验也报告了积极结果。

A staff member displays a bronze relic at a research institute of Sanxingdui ruins in Guanghan City, southwest China's Sichuan Province, Dec. 16, 2024. The second phase of the conservation and inherit ...